| Clinical Study "Common" Name (formal title) | Number of enrollees | Funding source (pharmaceutical company/National Institutes of Health [NIH]) | Year complete | Primary publication | Full study treatment protocol/patient disposition |
|---|---|---|---|---|---|
|
BEAT-ROP Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity |
143 |
Research to Prevent Blindness, National Eye Institute, and the Hermann Eye Fund. (NCT00622726) | 2010 | Mintz-Hittner HA, Kennedy KA, Chuang AZ for the BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ of retinopathy of prematurity. N Engl J Med. 2011;364:603-615. https://www.nejm.org/doi/10.1056/NEJMoa1007374 |
|